US FDA Eases Biosimilar Requirement On Use of Foreign Comparator PK Data

Bridge opening
The FDA is lifting the recommendation for a three-way PK bridge in biosimilar development. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Biosimilars

More from United States